Myriad Genetics buy Guggenheim
Start price
14.12.23
/
50%
€19.70
Target price
14.12.24
€21.01
Performance (%)
-30.46%
End price
15.12.24
€13.70
Summary
This prediction ended on 15.12.24 with a price of €13.70. Massive losses of -30.46% were the result for the BUY prediction by Guggenheim. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -41.629% | -41.629% | -43.854% |
| iShares Core DAX® | 1.842% | 1.387% | 8.651% |
| iShares Nasdaq 100 | 4.659% | -1.797% | 27.823% |
| iShares Nikkei 225® | 3.963% | -5.216% | 51.810% |
| iShares S&P 500 | 3.700% | 1.576% | 24.086% |
Comments by Guggenheim for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten